BRAIN Biotech AG

LSE:0RFI Stock Report

Market Cap: €50.2m

BRAIN Biotech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Aryan Moelker

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.7yrs
CEO ownershipn/a
Management average tenure3yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Aryan Moelker's remuneration changed compared to BRAIN Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-€9m

Mar 31 2024n/an/a

-€8m

Dec 31 2023n/an/a

-€8m

Sep 30 2023n/an/a

-€8m

Jun 30 2023n/an/a

-€7m

Mar 31 2023n/an/a

-€7m

Dec 31 2022n/an/a

-€7m

Sep 30 2022n/an/a

-€7m

Jun 30 2022n/an/a

-€8m

Mar 31 2022n/an/a

-€8m

Dec 31 2021n/an/a

-€4m

Sep 30 2021€957k€420k

-€5m

Jun 30 2021n/an/a

-€6m

Mar 31 2021n/an/a

-€6m

Dec 31 2020n/an/a

-€11m

Sep 30 2020€885k€280k

-€10m

Compensation vs Market: Insufficient data to establish whether Aryan's total compensation is reasonable compared to companies of similar size in the UK market.

Compensation vs Earnings: Aryan's compensation has increased whilst the company is unprofitable.

CEO

Aryan Moelker

4.7yrs

Tenure

€957,000

Compensation

Mr. Adriaan Moelker, also known as Aryan, serves as Director of SolasCure Limited. He has been Chairman of the Management Board and Chief Executive Officer of BRAIN Biotech AG (formerly known as B.R.A.I.N....

Leadership Team

NamePositionTenureCompensationOwnership
Adriaan Moelker
Chairman of the Management Board & CEO4.7yrs€957.00kno data
Ulrich Putsch
Co-Founderno datano datano data
Michael Schneiders
CFO & Member of Management Board2yrsno datano data
Ute Dechert
Vice President of Human Resources & Processes4yrsno datano data
Jurgen Eck
Consultant4.8yrs€392.00kno data
Martin Langer
MD & Executive VPno datano datano data
Alexander Pelzer
VP and Head of Research & Development - Zwingenberg1.8yrsno datano data
Robbert Hoekstra
Head of Group Finance2yrsno datano data
Paul Scholz
Technical Lead of Genome Editing Developmentno datano datano data

3.0yrs

Average Tenure

56.5yo

Average Age

Experienced Management: 0RFI's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Stephen Catling
Independent Member of Supervisory Board4yrs€31.00kno data
Michael Majerus
Independent Chairman of the Supervisory Board5.6yrs€51.00kno data
Anna Eichhorn
Vice Chairwoman of the Supervisory Board7.6yrs€53.00kno data
Christine Uekert
Independent Supervisory Board Member1.6yrsno datano data
Florian Schnabel
Supervisory Board Member1.6yrsno datano data

4.0yrs

Average Tenure

57yo

Average Age

Experienced Board: 0RFI's board of directors are considered experienced (4 years average tenure).